MASSACHUSETTS EYE AND EAR INFIRMARY
- Country
- ๐บ๐ธUnited States
- Ownership
- -
- Established
- 1824-01-01
- Employees
- -
- Market Cap
- -
Assessing the Utility of Plasma ctHPVDNA for Anal Cancer Screening
- Conditions
- Anal Dysplasia
- First Posted Date
- 2025-05-14
- Last Posted Date
- 2025-05-14
- Lead Sponsor
- Massachusetts Eye and Ear Infirmary
- Target Recruit Count
- 101
- Registration Number
- NCT06971276
- Locations
- ๐บ๐ธ
Department of Infectious Diseases, Mass General Hospital, Boston, Massachusetts, United States
Improving Clinical Efficiency by Reducing Scheduled Follow-ups Using Cochlear America's Population Mean Mapping Strategy
- Conditions
- DeafnessCochlear Hearing Loss
- First Posted Date
- 2025-05-07
- Last Posted Date
- 2025-05-09
- Lead Sponsor
- Massachusetts Eye and Ear Infirmary
- Target Recruit Count
- 48
- Registration Number
- NCT06960616
- Locations
- ๐บ๐ธ
Mass Eye and Ear, Boston, Massachusetts, United States
Subconjunctival Humira for Boston Keratoprosthesis
- Conditions
- Penetrating KeratoplastyMultiple Graft FailureOcular Cicatricial PemphigoidStevens-Johnson Syndrome
- Interventions
- First Posted Date
- 2025-04-13
- Last Posted Date
- 2025-04-13
- Lead Sponsor
- Massachusetts Eye and Ear Infirmary
- Target Recruit Count
- 8
- Registration Number
- NCT06926478
- Locations
- ๐บ๐ธ
Massachusetts Eye and Ear, Boston, Massachusetts, United States
ctDNA in Cutaneous Squamous Cell Carcinoma
- Conditions
- Cutaneous Squamous Cell Carcinoma
- First Posted Date
- 2025-03-25
- Last Posted Date
- 2025-03-26
- Lead Sponsor
- Massachusetts Eye and Ear Infirmary
- Target Recruit Count
- 60
- Registration Number
- NCT06875609
- Locations
- ๐บ๐ธ
Massachusetts Eye and Ear, Boston, Massachusetts, United States
The Glaucoma and Retinopathy Screening Study
- Conditions
- Glaucoma
- First Posted Date
- 2025-03-18
- Last Posted Date
- 2025-07-02
- Lead Sponsor
- Massachusetts Eye and Ear Infirmary
- Target Recruit Count
- 2000
- Registration Number
- NCT06882356
- Locations
- ๐บ๐ธ
Brigham and Women's Primary Care Associates of Longwood, Boston, Massachusetts, United States
ExCrossV Multi Site Trial for Vascularized High Risk Keratoplasty
- Conditions
- Corneal Transplant Failure
- First Posted Date
- 2024-12-31
- Last Posted Date
- 2024-12-31
- Lead Sponsor
- Massachusetts Eye and Ear Infirmary
- Target Recruit Count
- 96
- Registration Number
- NCT06753916
- Locations
- ๐บ๐ธ
University of California Irvine - Gavin Herbert Eye Institute, Irvine, California, United States
๐บ๐ธThe University of California Los Angeles - Doris Stein Eye Research Center, Los Angeles, California, United States
๐บ๐ธUniversity of Miami - Bascom Palmer Eye Institute, Miami, Florida, United States
Measurable Residual Disease Detection Using Tumor-Informed ctDNA Surveillance After Curative-Intent Treatment in HPV-Independent Squamous Cell Carcinoma of the Head and Neck
- Conditions
- Squamous Cell Carcinoma of Head and Neck
- First Posted Date
- 2024-12-20
- Last Posted Date
- 2025-05-18
- Lead Sponsor
- Massachusetts Eye and Ear Infirmary
- Target Recruit Count
- 75
- Registration Number
- NCT06744296
- Locations
- ๐บ๐ธ
Massachusetts Eye and Ear, Boston, Massachusetts, United States
CtDNA Liquid Biopsy for Early Assessment of Residual Disease in HPV-associated Head and Neck Cancer (Clear-HPVca)
- Conditions
- HPV Positive Oropharyngeal Squamous Cell Carcinoma
- First Posted Date
- 2024-12-12
- Last Posted Date
- 2024-12-12
- Lead Sponsor
- Massachusetts Eye and Ear Infirmary
- Target Recruit Count
- 103
- Registration Number
- NCT06730412
- Locations
- ๐บ๐ธ
Department of Otolaryngology - Head and Neck Surgery, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, United States
Testing Effectiveness of a Stochastic Noise Stimulator to Immediately Improve Balance and Gait
- Conditions
- Vestibular DisorderAging
- First Posted Date
- 2024-11-14
- Last Posted Date
- 2025-07-02
- Lead Sponsor
- Massachusetts Eye and Ear Infirmary
- Target Recruit Count
- 120
- Registration Number
- NCT06688578
- Locations
- ๐บ๐ธ
Johns Hopkins Medicine, Baltimore, Maryland, United States
๐บ๐ธMassachusetts Eye and Ear, Harvard Medical School, Boston, Massachusetts, United States
The Safety and Efficacy of Intravitreal Topotecan for the Treatment of Proliferative Vitreoretinopathy
- Conditions
- Rhegmatogenous Retinal DetachmentProliferative VitreoretinopathyProliferative Vitreo-Retinopathy
- Interventions
- First Posted Date
- 2024-05-22
- Last Posted Date
- 2024-11-25
- Lead Sponsor
- Massachusetts Eye and Ear Infirmary
- Target Recruit Count
- 50
- Registration Number
- NCT06425419